Endomysial (EMA) Antibody, IgG and IgM
Cyclic AMP, Plasma
Magnesium/Creatinine Ratio, Random, Urine
Beta-Hydroxybutyrate, Serum
Glucagon
Lysosomal Acid Lipase, Gene Variation
Monoclonal Protein (M Protein) Study, Serum
Alpha Fetoprotein (AFP), Tumor Marker, Serum/Plasam
CDH1 Gene Mutation Analysis
Brugada Syndrome Multi-Gene Panel, NGS
LDS
Sign up
Log in
LDS
/
Medical Tests
/
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test
Reference Ranges
Access to
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
is restricted.
Sign up now
Loading...